9CPL | pdb_00009cpl

The ubiquitin-associated domain of human thirty-eight negative kinase 1, fused to the 2TEL crystallization chaperone via a 2-glycine linker

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	SAM/Pointed domain	8039910	3000479	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A		e9cplA01	A: ATPD N-terminal domain-like	X: N-terminal domain of the delta subunit of the F1F0-ATP synthase	H: Galactose-binding domain-like	T: C1-set	F:	ECOD (20:10:01)

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	2TEL/Non-receptor tyrosine-protein kinase TNK1 fusion protein	protein binding binding protein domain specific binding DNA-binding transcription factor activity, RNA polymerase II-specific DNA-binding transcription repressor activity, RNA polymerase II-specific transcription regulator activity DNA-binding transcription repressor activity DNA-binding transcription factor activity DNA binding sequence-specific DNA binding double-stranded DNA binding nucleic acid binding RNA polymerase II transcription regulatory region sequence-specific DNA binding cis-regulatory region sequence-specific DNA binding protein binding binding protein domain specific binding DNA-binding transcription factor activity, RNA polymerase II-specific DNA-binding transcription repressor activity, RNA polymerase II-specific transcription regulator activity DNA-binding transcription repressor activity DNA-binding transcription factor activity DNA binding sequence-specific DNA binding double-stranded DNA binding nucleic acid binding RNA polymerase II transcription regulatory region sequence-specific DNA binding cis-regulatory region sequence-specific DNA binding sequence-specific double-stranded DNA binding transcription cis-regulatory region binding transcription regulatory region nucleic acid binding RNA polymerase II cis-regulatory region sequence-specific DNA binding DNA-binding transcription activator activity, RNA polymerase II-specific DNA-binding transcription activator activity adenyl ribonucleotide binding nucleotide binding purine ribonucleotide binding purine ribonucleoside triphosphate binding nucleoside phosphate binding ion binding purine nucleotide binding anion binding adenyl nucleotide binding ATP binding heterocyclic compound binding carbohydrate derivative binding ribonucleotide binding small molecule binding non-membrane spanning protein tyrosine kinase activity protein tyrosine kinase activity catalytic activity, acting on a protein kinase activity protein kinase activity transferase activity catalytic activity phosphotransferase activity, alcohol group as acceptor transferase activity, transferring phosphorus-containing groups	developmental process stem cell proliferation cell population proliferation cellular developmental process hemopoiesis cell differentiation anatomical structure development hematopoietic stem cell proliferation cell development cellular process neurogenesis multicellular organism development multicellular organismal process nervous system development developmental process stem cell proliferation cell population proliferation cellular developmental process hemopoiesis cell differentiation anatomical structure development hematopoietic stem cell proliferation cell development cellular process neurogenesis multicellular organism development multicellular organismal process nervous system development system development cellular component organization sexual reproduction reproductive process multicellular organismal reproductive process cytoplasm organization cellular component organization or biogenesis female gamete generation vitellogenesis gamete generation regulation of cellular process RNA metabolic process regulation of primary metabolic process nucleobase-containing compound metabolic process RNA biosynthetic process nucleic acid biosynthetic process DNA-templated transcription regulation of RNA metabolic process transcription by RNA polymerase II regulation of nucleobase-containing compound metabolic process regulation of RNA biosynthetic process regulation of transcription by RNA polymerase II regulation of biosynthetic process regulation of biological process biological regulation primary metabolic process regulation of macromolecule metabolic process nucleobase-containing compound biosynthetic process gene expression macromolecule biosynthetic process nucleic acid metabolic process regulation of gene expression biosynthetic process metabolic process regulation of macromolecule biosynthetic process regulation of DNA-templated transcription macromolecule metabolic process regulation of metabolic process mesenchymal cell apoptotic process apoptotic process cell death programmed cell death negative regulation of biological process negative regulation of RNA biosynthetic process negative regulation of cellular process negative regulation of nucleobase-containing compound metabolic process negative regulation of macromolecule metabolic process negative regulation of DNA-templated transcription negative regulation of transcription by RNA polymerase II negative regulation of metabolic process negative regulation of biosynthetic process negative regulation of macromolecule biosynthetic process negative regulation of RNA metabolic process protein phosphorylation phosphorylation macromolecule modification phosphate-containing compound metabolic process protein metabolic process protein modification process phosphorus metabolic process protein autophosphorylation	membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membraneless organelle intracellular membrane-bounded organelle nucleolus intracellular organelle lumen intracellular organelle cellular anatomical structure organelle lumen organelle membraneless organelle nuclear lumen membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membraneless organelle intracellular membrane-bounded organelle nucleolus intracellular organelle lumen intracellular organelle cellular anatomical structure organelle lumen organelle membraneless organelle nuclear lumen cytoplasm cytosol cell periphery plasma membrane membrane chromatin chromosome

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR013761	Sterile alpha motif/pointed domain superfamily	Homologous Superfamily
A	IPR036388	Winged helix-like DNA-binding domain superfamily	Homologous Superfamily
A	IPR000418	Ets domain	Domain
A	IPR036390	Winged helix DNA-binding domain superfamily	Homologous Superfamily
A	IPR046328	ETS family	Family
A	IPR003118	Pointed domain	Domain
A	IPR017441	Protein kinase, ATP binding site	Binding Site
A	IPR008266	Tyrosine-protein kinase, active site	Active Site
A	IPR020635	Tyrosine-protein kinase, catalytic domain	Domain
A	IPR011009	Protein kinase-like domain superfamily	Homologous Superfamily
A	IPR001452	SH3 domain	Domain
A	IPR049587	TNK(ACK)-like non-receptor tyrosine-protein kinases, SAM domain	Domain
A	IPR000719	Protein kinase domain	Domain
A	IPR055175	ACK/TNK-like, SAM domain	Domain
A	IPR050198	Non-receptor tyrosine kinases involved in cell signaling	Family
A	IPR001245	Serine-threonine/tyrosine-protein kinase, catalytic domain	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q13470	acute myeloid leukemia thrombocytopenia 5 chronic myelomonocytic leukemia fibrosarcoma thrombocytopenia congenital mesoblastic nephroma myeloproliferative disorder, chronic, with eosinophilia cancer Precursor B-Cell Lymphoblastic Leukemia-Lymphoma hematopoietic and lymphoid system neoplasm juvenile idiopathic arthritis macrocytosis, familial leukemia, acute lymphocytic, susceptibility to, 1 malignant ependymoma acute lymphoblastic leukemia acute myeloid leukemia thrombocytopenia 5 chronic myelomonocytic leukemia fibrosarcoma thrombocytopenia congenital mesoblastic nephroma myeloproliferative disorder, chronic, with eosinophilia cancer Precursor B-Cell Lymphoblastic Leukemia-Lymphoma hematopoietic and lymphoid system neoplasm juvenile idiopathic arthritis macrocytosis, familial leukemia, acute lymphocytic, susceptibility to, 1 malignant ependymoma acute lymphoblastic leukemia ovarian cancer Burkitt lymphoma subependymal giant cell astrocytoma substance dependence hematologic disease thyroid gland papillary carcinoma malignant glioma pancreatic intraductal papillary-mucinous neoplasm colorectal cancer drug dependence substance abuse tuberculosis large cell medulloblastoma medulloblastoma osteosarcoma breast cancer pilocytic astrocytoma childhood acute lymphoblastic leukemia psoriasis substance-related disorder glioblastoma hereditary thrombocytopenia and hematologic cancer predisposition syndrome ALK fusion gene-positive non-small-cell lung cancer large cell medulloblastoma Sjogren syndrome vascular disease Hashimoto thyroiditis lung adenocarcinoma thrombocytopenia due to immune destruction hypothyroidism non-small cell lung carcinoma uterine corpus leiomyoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.